Nothing for something? Estimating cost and value for beneficiaries from recent Medicare spending increases on HMO payments and drug benefits.

Pizer SD, Frakt AB, Feldman R. Nothing for something? Estimating cost and value for beneficiaries from recent Medicare spending increases on HMO payments and drug benefits. International Journal of Health Care Finance and Economics. 2009 Mar 1; 9(1):59-81.

Related HSR&D Project(s)

• IAD 06-112 – Outpatient Waiting Times, Outcomes, and Cost for VA Patients with Diabetes

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.    Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions

Search for Abstract from PubMed

---

Abstract:

The Medicare Modernization Act of 2003 added a new outpatient prescription drug benefit to Medicare and increased payments to HMOs. We estimate a nested logit model of plan choice to quantify the welfare benefits from these two expansion paths. We find that the addition of stand-alone prescription drug plans was welfare improving and produced nine times as much value per government dollar as the increase in payments to HMOs. In light of these results, we suggest that HMO bidding procedures should be modified to reduce payments to HMOs by about $67 billion over the next 10 years.